2416 related articles for article (PubMed ID: 11786451)
1. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.
Antithrombotic Trialists' Collaboration
BMJ; 2002 Jan; 324(7329):71-86. PubMed ID: 11786451
[TBL] [Abstract][Full Text] [Related]
2. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.
BMJ; 1994 Jan; 308(6921):81-106. PubMed ID: 8298418
[TBL] [Abstract][Full Text] [Related]
3. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
[TBL] [Abstract][Full Text] [Related]
5. Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.
Greenhalgh J; Bagust A; Boland A; Martin Saborido C; Oyee J; Blundell M; Dundar Y; Dickson R; Proudlove C; Fisher M
Health Technol Assess; 2011 Sep; 15(31):1-178. PubMed ID: 21888837
[TBL] [Abstract][Full Text] [Related]
6. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
7. Role of antiplatelet drugs in the prevention of cardiovascular events.
Tendera M; Wojakowski W
Thromb Res; 2003 Jun; 110(5-6):355-9. PubMed ID: 14592562
[TBL] [Abstract][Full Text] [Related]
8. Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients.
Sudlow CL; Mason G; Maurice JB; Wedderburn CJ; Hankey GJ
Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD001246. PubMed ID: 19821273
[TBL] [Abstract][Full Text] [Related]
9. Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events.
Squizzato A; Bellesini M; Takeda A; Middeldorp S; Donadini MP
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD005158. PubMed ID: 29240976
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease.
Aronow WS
Drugs Aging; 1999 Aug; 15(2):91-101. PubMed ID: 10495069
[TBL] [Abstract][Full Text] [Related]
11. Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients.
Hankey GJ; Sudlow CL; Dunbabin DW
Cochrane Database Syst Rev; 2000; (2):CD001246. PubMed ID: 10796426
[TBL] [Abstract][Full Text] [Related]
12. Collaborative overview of randomised trials of antiplatelet therapy--II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration.
BMJ; 1994 Jan; 308(6922):159-68. PubMed ID: 8312766
[TBL] [Abstract][Full Text] [Related]
13. Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease.
Keller TT; Squizzato A; Middeldorp S
Cochrane Database Syst Rev; 2007 Jul; (3):CD005158. PubMed ID: 17636787
[TBL] [Abstract][Full Text] [Related]
14. Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.
Jones L; Griffin S; Palmer S; Main C; Orton V; Sculpher M; Sudlow C; Henderson R; Hawkins N; Riemsma R
Health Technol Assess; 2004 Oct; 8(38):iii-iv, 1-196. PubMed ID: 15461876
[TBL] [Abstract][Full Text] [Related]
15. Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review.
Lane DA; Raichand S; Moore D; Connock M; Fry-Smith A; Fitzmaurice DA;
Health Technol Assess; 2013 Jul; 17(30):1-188. PubMed ID: 23880057
[TBL] [Abstract][Full Text] [Related]
16. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
Algra A; de Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
Cochrane Database Syst Rev; 2001; (4):CD001342. PubMed ID: 11687110
[TBL] [Abstract][Full Text] [Related]
17. Prolonged dual antiplatelet therapy in stable coronary disease: comparative observational study of benefits and harms in unselected versus trial populations.
Timmis A; Rapsomaniki E; Chung SC; Pujades-Rodriguez M; Moayyeri A; Stogiannis D; Shah AD; Pasea L; Denaxas S; Emmas C; Hemingway H
BMJ; 2016 Jun; 353():i3163. PubMed ID: 27334486
[TBL] [Abstract][Full Text] [Related]
18. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2006 Apr; (2):CD001820. PubMed ID: 16625549
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
Hankey GJ
Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
[TBL] [Abstract][Full Text] [Related]
20. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2007 Jul; (3):CD001820. PubMed ID: 17636684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
